SpaceX Stock Drops Over 40%, Wall Street Rushes to Issue Structured Notes
Claire Weston
SpaceX shares have fallen more than 40% from their post-IPO peak, and at least five Wall Street firms are rushing to issue structured notes tied to the stock — offering downside cushions in exchange for capped returns as volatility spikes.
What are structured notes, and why are they flooding in now?
A structured note — a financial product that bundles a bond with derivatives — is essentially a trade-off: you give up profits if the stock soars, and in return you are shielded from losses up to a certain decline.
SpaceX went public in June and has been wildly volatile since. The higher the volatility, the more room banks have to price derivatives. This means → banks can engineer products with "attractive-looking" terms while earning fatter fees for themselves.
Morgan Stanley, Citi, Wells Fargo, RBC Capital Markets, and Marex Group — at least five firms have moved in simultaneously. Marex's head of U.S. structured-product sales, Sarah Laconte, called it "one of the fastest launches of structured products linked to a newly issued security."
How do these products actually work?
Marex's note: nine-month term, paying at least 1.8% per month in fixed interest. If SpaceX stock falls 35% or less by maturity, principal is returned in full; beyond 35%, the investor absorbs the entire loss. An autocall feature returns principal early if the stock recovers to its initial price on an observation date.
Morgan Stanley's note: matures in early 2028. If SpaceX stock is flat or higher, the investor collects a 40% fixed return. That same payout applies as long as the decline stays within 50%. Once the stock drops past 50%, the investor is fully exposed to the downside.
In plain terms = both products follow the same logic — they cushion you within a set decline range, but cap your upside. Once the stock breaks through the protection threshold, your loss is no different from owning the shares outright.
Who is buying — and who should think twice?
These products target high-net-worth individuals, family offices, and discretionary managers — not a typical retail channel.
Since its IPO, SpaceX has spawned a full derivatives ecosystem — options, leveraged ETFs — and structured notes sit at the highest-fee end of that chain. This reflects Wall Street's familiar playbook: wrap a hot name in a high-margin product.
Yet Aaron Brachman, executive managing director at Steward Partners' Washington Wealth Group, pushed back sharply. He sees a "risk-reward inversion" — upside is capped, but once the protection barrier is breached the downside is unlimited. His blunt question: "In that case, why not just buy the stock?"
What to watch next?
Brachman noted that SpaceX options-market liquidity keeps improving, giving more banks confidence to price the risk. This means → more products of this kind will keep appearing; supply is not slowing down.
The real unknown is singular: whether SpaceX's stock price stabilises. If it keeps falling and breaks through protection thresholds, the "downside cushion" becomes meaningless and investors face full losses.
In plain terms = the protection is conditional, not insurance. If the stock steadies, these notes act like high-yield deposits. If it collapses, they are a one-way ticket to loss.
Content is for reference only, not financial advice.